rs63750612

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001377265.1(MAPT):​c.1708G>A​(p.Ala570Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00261 in 1,614,058 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 44 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 56 hom. )

Consequence

MAPT
NM_001377265.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -0.997
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019565523).
BP6
Variant 17-45991562-G-A is Benign according to our data. Variant chr17-45991562-G-A is described in ClinVar as [Benign]. Clinvar id is 98205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-45991562-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0141 (2152/152232) while in subpopulation AFR AF= 0.0491 (2040/41524). AF 95% confidence interval is 0.0474. There are 44 homozygotes in gnomad4. There are 1000 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 44 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPTNM_001377265.1 linkc.1708G>A p.Ala570Thr missense_variant Exon 8 of 13 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkc.1708G>A p.Ala570Thr missense_variant Exon 8 of 13 1 NM_001377265.1 ENSP00000262410.6 A0A7I2PJZ2

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2154
AN:
152114
Hom.:
45
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0493
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00550
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00910
GnomAD3 exomes
AF:
0.00364
AC:
915
AN:
251212
Hom.:
26
AF XY:
0.00264
AC XY:
359
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.0499
Gnomad AMR exome
AF:
0.00263
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000617
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00141
AC:
2061
AN:
1461826
Hom.:
56
Cov.:
33
AF XY:
0.00117
AC XY:
851
AN XY:
727212
show subpopulations
Gnomad4 AFR exome
AF:
0.0499
Gnomad4 AMR exome
AF:
0.00302
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000405
Gnomad4 OTH exome
AF:
0.00321
GnomAD4 genome
AF:
0.0141
AC:
2152
AN:
152232
Hom.:
44
Cov.:
32
AF XY:
0.0134
AC XY:
1000
AN XY:
74430
show subpopulations
Gnomad4 AFR
AF:
0.0491
Gnomad4 AMR
AF:
0.00549
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00900
Alfa
AF:
0.00253
Hom.:
17
Bravo
AF:
0.0162
ESP6500AA
AF:
0.0454
AC:
200
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00421
AC:
511
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 21, 2023
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
VIB Department of Molecular Genetics, University of Antwerp
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Mar 19, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

MAPT-Related Spectrum Disorders Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Frontotemporal dementia Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.28
DANN
Benign
0.85
DEOGEN2
Benign
0.28
T;.;.;.;.;.;.;.;.;T;.;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.83
T;T;T;T;T;T;T;.;.;.;.;.
MetaRNN
Benign
0.0020
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.41
N;.;N;.;.;.;.;.;N;N;.;.
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.47
N;N;N;N;N;N;N;N;N;.;.;.
REVEL
Benign
0.0050
Sift
Benign
0.43
T;T;T;T;T;T;T;T;T;.;.;.
Sift4G
Benign
0.69
T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.010
B;B;B;.;B;B;B;B;B;B;B;.
Vest4
0.029
MVP
0.30
MPC
0.15
ClinPred
0.0023
T
GERP RS
-8.8
Varity_R
0.026
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs63750612; hg19: chr17-44068928; COSMIC: COSV52248827; COSMIC: COSV52248827; API